ThirdLaw Molecular, Inc.

ThirdLaw Molecular has pioneered the development of Spiroligomer™ molecules – a new, patent-protected, therapeutic modality for targeted drug discovery.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Blue Bell, PA, USA
  • Currency USD
  • Founded 2020
  • Employees 9
  • Incorporation Type C-corp
  • Website thirdlawtx.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free